Rezolute Inc (RZLT)
Healthcare
Biotechnology
4.90 $
+4.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Rezolute Inc (RZLT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -14 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -11 | -11 | -13 | -15 | -19 | -16 | -14 | -17 | -22 | -17 | -20 | -14 | -73 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 1.8 | 1.8 | 1.8 | 1.9 | 1.8 | 1.4 | 1.4 | 1.9 | 2.4 | 2.5 | 3.4 | 4.4 | 13 | |
| 1.2 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.1 | 1.0 | 1.0 | -1.3 | 2.4 | -1.4 | 1.2 | 0.0 | 0.2 | -1.2 | -0.4 | -1.7 | -3.0 | |
| 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -6.4 | 2.6 | 18 | 8.7 | 20 | -49 | 11 | 23 | 0.3 | -68 | 23 | 12 | -33 | |
| 0.0 | 0.0 | -0.3 | 0.0 | 63 | 5.5 | 0.7 | 0.0 | 101 | 0.9 | 0.4 | 0.7 | 103 | |
| -18 | -8.0 | 4.4 | -6.6 | 64 | -60 | -1.5 | 5.7 | 80 | -85 | 2.8 | -0.7 | -3.4 | |
| -11 | -11 | -13 | -15 | -19 | -16 | -14 | -17 | -22 | -17 | -20 | -14 | -73 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.